Skip to the content

Boston Agenda

Wednesday, May 20, 2020

Boston Marriott Cambridge | 50 Broadway, Cambridge, MA 02142


Drug Development And Manufacturing Outsourcing In The Twenty-Twenties
New Generations Meet Best Practices


Registration & Networking Breakfast

Collect your badge at registration and head over to our catered breakfast spread to enjoy while you mingle with fellow attendees.

Welcome & Conference Chair Opening Remarks

Louis Garguilo, Chief Editor & Conference Chair of Outsourced Pharma, kicks off the morning.

Standing On External Supply Chain Shoulders

Company Spotlight: Amylyx Pharmaceuticals
A veteran of two decades at Biogen joins a biotech co-founded by scientists in their early twenties. The result? A mix of millennial sentiment and established practices to form the outsourcing strategy for Cambridge’s own Amylyx Pharmaceuticals. Hear their story, and learn how your company can also blend new and established ideas for successful outsourcing and CDMO partnerships.

  • Joshua Cohen, Co-Founder & CEO | Amylyx Pharmaceuticals
  • Thomas Holmes, Global Head, Supply Chain | Amylyx Pharmaceuticals
  • Justin Klee, Co-Founder & President | Amylyx Pharmaceuticals
Networking Refreshment Break

Head over to the exhibit hall to grab a quick snack while you digest the previous discussion with your peers.

How To Bring In A New Generation Of Workers

What are today’s strategies to develop and deploy skilled workers at both drug sponsors and CDMOs? We have a leading authority on the subject, founder of three Centers for Biopharma Education and Training, Kamal Rashid, Ph.D., to provide some answers. Also joining our panel are veterans of the Boston-area biotech and pharma industry, and the CEO of a local CDMO, to share approaches, successes, and challenges in obtaining the right personnel.

  • Vincent Kosewski, SVP, Manufacturing & Supply Chain Management | Kala Pharmaceuticals
  • Edward Price, CEO | SEQENS
  • Kamal Rashid, Ph.D., Director, Center for Biopharma Education and Training | Albany College of Pharmcacy and Health Sciences
  • Barry Rubenstein, VP, Human Resources | Kala Pharmaceuticals
Networking Lunch

Lunch is served! Take the hour to fill up (if you haven't already!) and network with exhibitors and peers.

Keynote: Joanne Beck, COO | Boston Pharmaceuticals

Joanne Beck, whose career includes executive positions and years of outsourcing experience at AbbVie/Abbott, Shire, and Celgene, will discuss her new role and the new drug development model at Boston Pharmaceuticals — one that leans heavily on working efficiently with CDMOs. Beck will also be accompanied by some members of the younger generations at Boston Pharmaceuticals.

Trading Places: Advice From Professionals Who Have Been On Both Sides

Many outsourcing professionals today have worked on both side of the equation – at CDMOs and biopharma companies. Will these resources help bring the two sides closer together, improve communication, and ultimately outsourcing results? How can you take advantage of their experience in your organization? And what advice can they give us all having “dual-track” careers.

  • Ken Baker, Director, CMC Project Lead | Sage Therapeutics
  • Charlie Montgomery, Senior Director, CMC | Aldeyra Therapeutics
  • Bernhard Paul, President & Principal Consultant | Carinth Consulting
  • Lisa Wyman, VP, Technical Operations & Quality | Acceleron Pharma
  • Moderator: Patti Seymour, Managing Director | BioProcess Technology Group, BDO USA, LLP
Networking Refreshment Break

Continue the conversation as you fill up on locally inspired treats!

A New Decade Of Outsourcing: What Can We Expect?

Will the “Twenty-Twenties” be as exciting as they sound? Our panelists may not have decade-long vision, but these professionals have selected four key areas where we might focus: continuous manufacturing; cell and gene therapy influences; new sponsor-CDMO service models; and “Supply Chain 4.0." Also: bring your own prognostications for discussion.

  • Darren Dasburg, (former) VP & Head Learning and Development Global Operations | AstraZeneca
  • Shawn Eisenberg, Executive Director, Manufacturing & Supply Chain | ImmunoGen
  • Praveen Prasanna, Sr. Director, Technical Operations | AVEO Oncology
  • Jana Spes, Head of Pharmaceutical Development & Manufacturing Sciences | Ironwood Pharmaceuticals
  • Moderator: Mark Butchko, Sr. Director, Quality Assurance - Development | Eli Lilly and Company
Networking Reception

You're invited to join us for an open bar reception featuring heavy hors d'oeuvre and desserts!

Conference Concludes